Doctor who testified about ivermectin as early COVID treatment forced out of hospital board meeting

03/07/2023 / By Kevin Hughes

Talking about using ivermectin as early treatment for Wuhan coronavirus (COVID-19) could get someone kicked out of a hospital board meeting.

Dr. John Littell – a board-certified family physician based in Ocala, Florida – was expelled while testifying during a Feb. 23 meeting of the Sarasota County Public Hospital board. He recounted the events at the board meeting during a March 2 conversation with Veronika Kyrylenko, senior editor at the New American magazine. Littell told her that his testimony would have been longer if he had been given more time.

According to Kyrylenko, initial reports about the incident suggested that the content of the physician’s speech drew the ire of hospital board members. A later report by the Associated Press clarified that Littell’s behavior “presented a safety risk and violated clearly set rule of decorum for the public meeting,” which prompted his expulsion.

The doctor found the expulsion really upsetting since it could have been avoided. He explained that he simply walked over to a sympathetic female board member to give thanks for supporting him. At this point, three uniformed officers escorted him out of the meeting room.

“So, I don’t want to be a hero for this. I just want it to be known that I believe the hospital overreacted. And I think had I been a friendly person in their mind, if I had been supporting their narrative, I don’t believe they would have had me treated this way. I guess it’s up to the others who know about the security there to answer that question,” Littell said.

Littell touches on pandemic-era hospital homicide

Littell mentioned that he wanted to present several cases of ivermectin successfully being used to treat COVID-19 infection. In particular, he cited a “big shot” town mayor allowed to get ivermectin whereas other patients were not allowed. Moreover, he recounted stories of COVID patients isolated from their family members that could serve as patient advocates.

“They were put on CDC [Centers for Disease Control and Prevention] protocols which led, in many cases, to death on a ventilator. So, there were big steps that could have taken place between them showing up in the ER [emergency room]. Obviously, the idea was to keep them out of the hospital and the ventilator, and give them the multi-drug regimen that many of us physicians had already implemented around the world,” he told Kyrylenko.

Littell added that this multi-drug regimen – which included ivermectin and high doses of steroids and anticoagulants – had been effective in the outpatient setting. Had hospitals allowed this regimen, it would have been effective in the in-patient setting. (Related: A “death sentence”: Physicians blast NIH guideline restricting early treatment for hospitalized COVID-19 patients.)

The New American senior editor agreed, saying that it is common knowledge for large hospitals to refuse generic medicines for their patients. This is because they are incentivized by the government to use expensive drugs which may or may not be necessarily safe or effective.

Littell ultimately remarked that ivermectin could be awarded a Nobel Prize for being an effective medicine for human consumption. It is not only useful as an antiparasitic, but also an anti-inflammatory and antiviral drug.

Follow IvermectinScience.com for more news about ivermectin as a treatment for COVID-19.

Watch the full conversation between Dr. John Littell and Veronika Kyrylenko of the New American below.

This video is from the The New American channel on Brighteon.com.